Skip to content

A Clinical Trial on Nelliyathy Kashayam in the Management of Madhumegam (Diabetes Mellitus)

A Prospective Open Labelled, Single Arm, Non- Randomized, Single Centric, Phase II Clinical Trail To Determine The Effectiveness Of Nelliyathy Kashayam In The Management Of Madhumega Noi (Diabetes Mellitus) - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086594
Enrollment
40
Registered
2025-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Nelliyathy Kashayam: Aalaaku (84ml),Twice a day Duration : 90 days Control Intervention1: Nil: Nil

Sponsors

Government Siddha Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Even if patient is having any one among the three (WHO criteria 2019): FBS - above126 mg/dl and below 250mg/dl or PPBS - above 200mg/dl and below 350mg /dl or HbA1c 6.5 to 10 Patients with symptoms of polyuria, polydipsia, polyphagia,asthenia,nocturia,obesity (metabolic syndrome),numbness, tingling sensation.

Exclusion criteria

Exclusion criteria: Type 1 diabetes mellitus Gestational DM Diabetes insipidus Pregnancy Lactating mother Chronic kidney disease Chronic lever disease Ischemic heart diseases

Design outcomes

Primary

MeasureTime frame
If during treatment or after treatment FBS became below 126 mg dl & PPBS below 200 mg dl and HbA1c below 6.5Timepoint: 90 days

Secondary

MeasureTime frame
Reduction of the sign and symptoms of polyuria, polydipsia, polyphagia, asthenia, nocturia, numbness, tingling sensation, nausea, mood changes and irritability, difficulty in concentrationTimepoint: 90 days

Countries

India

Contacts

Public ContactDr T Komallavalli MDs PhD

Government Siddha Medical College, Palayamkottai

komalaarumugam1@gmail.com9788122691

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026